$VRTX
VERTEX PHARMACEUTICALS INC / MA

2012 Q3 Form 10-Q Financial Statement

#000104746912010125 Filed on November 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2011 Q3
Revenue $336.0M $659.2M
YoY Change -49.03% 2669.75%
Cost Of Revenue $30.68M $35.29M
YoY Change -13.05% 1002.66%
Gross Profit $305.3M $623.9M
YoY Change -51.06% 2928.71%
Gross Profit Margin 90.87% 94.65%
Selling, General & Admin $97.68M $110.7M
YoY Change -11.72% 126.29%
% of Gross Profit 31.99% 17.74%
Research & Development $200.2M $189.1M
YoY Change 5.88% 10.95%
% of Gross Profit 65.56% 30.3%
Depreciation & Amortization $8.600M $7.700M
YoY Change 11.69% 13.24%
% of Gross Profit 2.82% 1.23%
Operating Expenses $297.8M $299.7M
YoY Change -0.62% 36.66%
Operating Profit -$1.071M $215.7M
YoY Change -100.5% -208.56%
Interest Expense -$13.00K $7.059M
YoY Change -100.18% -175.1%
% of Operating Profit 3.27%
Other Income/Expense, Net -$4.041M
YoY Change
Pretax Income -$5.112M $200.6M
YoY Change -102.55% -195.99%
Income Tax $21.36M -$27.84M
% Of Pretax Income -13.88%
Net Earnings -$57.54M $221.1M
YoY Change -126.02% -205.79%
Net Earnings / Revenue -17.13% 33.54%
Basic Earnings Per Share -$0.27 $1.06
Diluted Earnings Per Share -$0.27 $1.02
COMMON SHARES
Basic Shares Outstanding 213.8M shares 206.0M shares
Diluted Shares Outstanding 213.8M shares 219.3M shares

Balance Sheet

Concept 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.299B $659.0M
YoY Change 97.12% -45.22%
Cash & Equivalents $436.9M $542.5M
Short-Term Investments $862.0M $116.0M
Other Short-Term Assets $110.0M $74.00M
YoY Change 48.65% 311.11%
Inventory $86.28M $68.00M
Prepaid Expenses
Receivables $139.6M $445.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.635B $1.246B
YoY Change 31.18% 1.63%
LONG-TERM ASSETS
Property, Plant & Equipment $124.1M $101.3M
YoY Change 22.59% 55.8%
Goodwill $30.99M $33.50M
YoY Change -7.49%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.39M $13.79M
YoY Change -24.61% -73.49%
Total Long-Term Assets $1.084B $846.0M
YoY Change 28.17% 27.6%
TOTAL ASSETS
Total Short-Term Assets $1.635B $1.246B
Total Long-Term Assets $1.084B $846.0M
Total Assets $2.719B $2.092B
YoY Change 29.96% 10.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.73M $49.25M
YoY Change 70.02% 96.99%
Accrued Expenses $273.3M $229.9M
YoY Change 18.89% 71.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $98.00M
YoY Change 81.48%
Total Short-Term Liabilities $406.7M $549.0M
YoY Change -25.91% 75.96%
LONG-TERM LIABILITIES
Long-Term Debt $400.0M $400.0M
YoY Change 0.0% -17.86%
Other Long-Term Liabilities $28.74M $7.848M
YoY Change 266.2% -97.2%
Total Long-Term Liabilities $28.74M $7.848M
YoY Change 266.2% -98.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $406.7M $549.0M
Total Long-Term Liabilities $28.74M $7.848M
Total Liabilities $1.454B $1.512B
YoY Change -3.83% 22.03%
SHAREHOLDERS EQUITY
Retained Earnings -$3.446B
YoY Change
Common Stock $4.474B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.028B $580.0M
YoY Change
Total Liabilities & Shareholders Equity $2.719B $2.092B
YoY Change 29.96% 10.75%

Cashflow Statement

Concept 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$57.54M $221.1M
YoY Change -126.02% -205.79%
Depreciation, Depletion And Amortization $8.600M $7.700M
YoY Change 11.69% 13.24%
Cash From Operating Activities $106.0M $42.90M
YoY Change 147.09% -126.16%
INVESTING ACTIVITIES
Capital Expenditures -$21.40M -$10.00M
YoY Change 114.0% -7.41%
Acquisitions
YoY Change
Other Investing Activities -$109.9M $31.50M
YoY Change -448.89% 275.0%
Cash From Investing Activities -$131.3M $21.50M
YoY Change -710.7% -995.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.200M 20.00M
YoY Change -59.0% -94.98%
NET CHANGE
Cash From Operating Activities 106.0M 42.90M
Cash From Investing Activities -131.3M 21.50M
Cash From Financing Activities 8.200M 20.00M
Net Change In Cash -17.10M 84.40M
YoY Change -120.26% -63.64%
FREE CASH FLOW
Cash From Operating Activities $106.0M $42.90M
Capital Expenditures -$21.40M -$10.00M
Free Cash Flow $127.4M $52.90M
YoY Change 140.83% -134.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000875320
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
216827066 shares
CY2011Q3 us-gaap Costs And Expenses
CostsAndExpenses
443493000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
215707000 USD
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
77000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
7059000 USD
CY2011Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-8115000 USD
CY2011Q3 vrtx Collaborative Revenues
CollaborativeRevenues
231066000 USD
CY2011Q3 us-gaap Revenues
Revenues
659200000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
494130000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
24610000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
328546000 USD
us-gaap Revenues
Revenues
847286000 USD
CY2011Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
105800000 USD
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
35285000 USD
CY2011Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
3121000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
189052000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
110654000 USD
CY2011Q3 us-gaap Restructuring Charges
RestructuringCharges
-419000 USD
dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
419595000 USD
CY2011Q3 us-gaap Royalty Revenue
RoyaltyRevenue
8539000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
200610000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-27842000 USD
CY2011Q3 us-gaap Profit Loss
ProfitLoss
228452000 USD
CY2011Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7342000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
221110000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
40689000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
9689000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
521268000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
278840000 USD
us-gaap Restructuring Charges
RestructuringCharges
1082000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
105800000 USD
us-gaap Costs And Expenses
CostsAndExpenses
957368000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-110082000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1681000 USD
CY2012Q3 us-gaap Revenues
Revenues
336006000 USD
us-gaap Interest Expense
InterestExpense
26022000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-15933000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-150356000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3394000 USD
us-gaap Profit Loss
ProfitLoss
-146962000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-17907000 USD
us-gaap Net Income Loss
NetIncomeLoss
-129055000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-17907000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
31076000 USD
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
209303995 shares
us-gaap Revenues
Revenues
1193048000 USD
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2011Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
493602000 USD
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
206002000 shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219349000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
204262000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
204262000 shares
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
337077000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1113240000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
79808000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5112000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
68391000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-26467000 USD
us-gaap Profit Loss
ProfitLoss
26941000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-57543000 USD
us-gaap Net Income Loss
NetIncomeLoss
-30884000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213767000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213767000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211053000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211053000 shares
CY2011Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
228214000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-146840000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-26210000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
27578000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7342000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475320000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
57825000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
220872000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-128933000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57286000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30247000 USD
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
51878000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
183135000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
112430000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14889000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1331254000 USD
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
34090000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78106000 USD
CY2011Q4 us-gaap Indefinite Lived Intangible Assets
IndefiniteLivedIntangibleAssets
663500000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
30992000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11268000 USD
CY2011Q4 us-gaap Assets
Assets
2204280000 USD
CY2012Q3 us-gaap Indefinite Lived Intangible Assets
IndefiniteLivedIntangibleAssets
663500000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
30992000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
74642000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
255662000 USD
CY2012Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
861656000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
45037000 USD
CY2011Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4932000 USD
CY2011Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
12075000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
392348000 USD
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14000 USD
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
us-gaap Inventory Write Down
InventoryWriteDown
78000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
433132000 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
118095000 USD
CY2011Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
21381000 USD
CY2011Q4 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
400000000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
243707000 USD
CY2011Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
55950000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7287000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
1238768000 USD
CY2012Q3 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
400000000 USD
CY2011Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
37036000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
2072000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4200659000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1053000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3414835000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
786843000 USD
CY2011Q4 us-gaap Minority Interest
MinorityInterest
141633000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
928476000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2204280000 USD
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13944000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216341505 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
209303995 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216341505 shares
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
503973000 USD
CY2011Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
694150000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1226447000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
313000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-42000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
324000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
164000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
115146000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
183022000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
90002000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87537000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1097000 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
132266000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
397000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1263000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25317000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
89172000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
6396000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
11856000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-15933000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-18244000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
542545000 USD
vrtx Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66824000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10053000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12103000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
94704000 USD
vrtx Discount Rate For Payments Made Within30 Days
DiscountRateForPaymentsMadeWithin30Days
0.02 pure
vrtx Period Prior To Expiration Date Which Distributors Have Right To Return Product
PeriodPriorToExpirationDateWhichDistributorsHaveRightToReturnProduct
6
vrtx Period After Expiration Date Which Distributors Have Right To Return Product
PeriodAfterExpirationDateWhichDistributorsHaveRightToReturnProduct
12
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243197000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30884000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-3011000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9755000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52752000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-359928000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1097000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
251089000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
923123000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
60000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25266000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
29000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-13994000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
545000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
600188000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-432973000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1097000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
108742000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
50000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
58742000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
346000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
299348000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-38434000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436886000 USD
us-gaap Interest Paid
InterestPaid
6700000 USD
us-gaap Interest Paid
InterestPaid
6812000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
24179000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
167996000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
27552000 USD
CY2011Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
69363000 USD
CY2012Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
73331000 USD
vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
219854000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-30884000 USD
CY2011Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
10000 USD
CY2011Q3 vrtx Research And Development Expense Associated With Collaborative Programs
ResearchAndDevelopmentExpenseAssociatedWithCollaborativePrograms
45000000 USD
vrtx Research And Development Expense Associated With Collaborative Programs
ResearchAndDevelopmentExpenseAssociatedWithCollaborativePrograms
110000000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
42852000 USD
CY2012Q3 vrtx Collaborative Revenues
CollaborativeRevenues
6919000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-129055000 USD
us-gaap Use Of Estimates
UseOfEstimates
<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="FONT-FAMILY: times"><font size="2"><i>Use of Estimates and Summary of Significant Accounting Policies </i></font></p> <p style="FONT-FAMILY: times"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, noncontrolling interest (Alios), income tax provision, derivative instruments and debt securities. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known. </font></p> <p style="FONT-FAMILY: times"><font size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the 2011 Annual Report on Form&#160;10-K. </font></p></td></tr></table>
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-57543000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-57543000 USD
CY2011Q3 us-gaap Undistributed Earnings
UndistributedEarnings
-2136000 USD
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
218974000 USD
CY2011Q3 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
-2007000 USD
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
222845000 USD
CY2011Q3 vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
4398000 shares
CY2011Q3 vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
60000 shares
CY2011Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8889000 shares
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
119000 USD
CY2011Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
969031000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-129055000 USD
CY2012Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
72700000 USD
CY2012Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
1298327000 USD
CY2012Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
235000 USD
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
20000 USD
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
74954000 USD
CY2012Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4506000 USD
CY2011Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32213000 USD
CY2012Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
58452000 USD
CY2011Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
47010000 USD
CY2012Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
23317000 USD
CY2011Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
33207000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
86275000 USD
CY2012Q2 us-gaap Inventory Write Down
InventoryWriteDown
78000000 USD
CY2011Q2 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 leases
CY2011Q2 vrtx Square Footage Of Leased Property
SquareFootageOfLeasedProperty
1100000 area
CY2011Q2 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 buildings
vrtx Initial Term Of Lease Agreement
InitialTermOfLeaseAgreement
15
vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
10
CY2012Q3 vrtx Land Lease Expense
LandLeaseExpense
1600000 USD
vrtx Land Lease Expense
LandLeaseExpense
5000000 USD
CY2011Q3 vrtx Land Lease Expense
LandLeaseExpense
1700000 USD
vrtx Land Lease Expense
LandLeaseExpense
2200000 USD
CY2012Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-339000 USD
CY2012Q3 vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
2355000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27582000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-888000 USD
CY2011Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-294000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-830000 USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
86649000 USD
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29414000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
89172000 USD
CY2009Q3 us-gaap Debt Instrument Increase Additional Borrowings
DebtInstrumentIncreaseAdditionalBorrowings
155000000 USD
CY2009Q3 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
122200000 USD
CY2011Q1 vrtx Proceeds From Milestone Payment
ProceedsFromMilestonePayment
50000000 USD
CY2011Q1 vrtx Collaborative Arrangement Portion Of Notes Redeemed Upon Approval Milestone
CollaborativeArrangementPortionOfNotesRedeemedUponApprovalMilestone
50000000 USD
CY2011Q4 vrtx Collaborative Arrangement Milestone Payment Earned
CollaborativeArrangementMilestonePaymentEarned
105000000 USD
CY2009Q3 vrtx Collaborative Arrangement Number Of Purchase Agreements Related To Sale Of Future Milestone Payments
CollaborativeArrangementNumberOfPurchaseAgreementsRelatedToSaleOfFutureMilestonePayments
2 agreements
CY2009Q3 vrtx Proceeds From Sale Of Collaborative Arrangement Future Milestone Payments
ProceedsFromSaleOfCollaborativeArrangementFutureMilestonePayments
32800000 USD
CY2009Q3 vrtx Collaborative Arrangement Aggregate Value Of Future Milestone Payments Sold
CollaborativeArrangementAggregateValueOfFutureMilestonePaymentsSold
95000000 USD
CY2011 vrtx Proceeds From Purchase Of Collaborative Arrangement Aggregate Value Of Future Milestone Payments Sold
ProceedsFromPurchaseOfCollaborativeArrangementAggregateValueOfFutureMilestonePaymentsSold
95000000 USD
CY2011Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2960000 USD
CY2011Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-1084000 USD
CY2011Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
-7031000 USD
CY2011Q3 vrtx September2009 Financial Transaction Expenses
September2009FinancialTransactionExpenses
11075000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
13757000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
430000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
-16363000 USD
vrtx September2009 Financial Transaction Expenses
September2009FinancialTransactionExpenses
29690000 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
696000 USD
CY2011Q3 vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
2483000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
11137000 USD
vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
7329000 USD
us-gaap Restructuring Charges
RestructuringCharges
1650000 USD
CY2011Q3 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
3685000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
11158000 USD
vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
7065000 USD
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2012Q3 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
84300000 USD
CY2011Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2700000000 USD
CY2010Q4 us-gaap Restructuring Reserve
RestructuringReserve
29595000 USD
CY2011Q3 us-gaap Restructuring Reserve
RestructuringReserve
26584000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
26313000 USD
CY2012Q3 us-gaap Restructuring Reserve
RestructuringReserve
24155000 USD
CY2011Q2 us-gaap Restructuring Reserve
RestructuringReserve
28205000 USD
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
24830000 USD
CY2012Q3 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
3726000 USD
CY2011Q3 vrtx Interest Expense And Amortization Of Deferred Issuance Costs
InterestExpenseAndAmortizationOfDeferredIssuanceCosts
-3742000 USD
CY2012Q3 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1298542000 USD
CY2011Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
968922000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
303501000 USD
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
25586000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1052149000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
98047000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
30680000 USD
CY2012Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
7856000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200161000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97684000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
161147000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
31023000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
593076000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
326344000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
519000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
86649000 USD
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
279466000 USD
CY2012Q3 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
215956000 USD
CY2012Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
19559000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
4560000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1443000 USD
us-gaap Interest Expense
InterestExpense
12860000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21355000 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31076000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41450000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
57825000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139629000 USD
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35123000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
1634523000 USD
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
32166000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124148000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10393000 USD
CY2012Q3 us-gaap Assets
Assets
2718823000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
83732000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
273285000 USD
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
27303000 USD
CY2012Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4596000 USD
CY2012Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3871000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
406731000 USD
CY2012Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
103626000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28739000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
1454077000 USD
CY2012Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
38299000 USD
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
2141000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4471727000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-416000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3445719000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
1027733000 USD
CY2012Q3 us-gaap Minority Interest
MinorityInterest
198714000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2718823000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD

Files In Submission

Name View Source Status
0001047469-12-010125-index-headers.html Edgar Link pending
0001047469-12-010125-index.html Edgar Link pending
0001047469-12-010125.txt Edgar Link pending
0001047469-12-010125-xbrl.zip Edgar Link pending
a2211595z10-q.htm Edgar Link pending
a2211595zex-10_1.htm Edgar Link pending
a2211595zex-10_2.htm Edgar Link pending
a2211595zex-10_3.htm Edgar Link pending
a2211595zex-10_4.htm Edgar Link pending
a2211595zex-31_1.htm Edgar Link pending
a2211595zex-31_2.htm Edgar Link pending
a2211595zex-32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g198882kii001.jpg Edgar Link pending
g198882kmi001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20120930.xml Edgar Link completed
vrtx-20120930.xsd Edgar Link pending
vrtx-20120930_cal.xml Edgar Link unprocessable
vrtx-20120930_def.xml Edgar Link unprocessable
vrtx-20120930_lab.xml Edgar Link unprocessable
vrtx-20120930_pre.xml Edgar Link unprocessable